The Role of PARP Inhibitors in Prostate Cancer
Tuesday, August 9, 2016
Christopher E. Barbieri, M.D., Ph.D., surgeon and researcher in prostate cancer, talks to Targeted Oncology about the role of PARP inhibitors in castration-resistant prostate cancer.